OCIAD2 Antikörper (AA 65-154)

Produktnummer ABIN718031

Der Kaninchen Polyklonal anti-OCIAD2 Antikörper wird verwendet zum Nachweis von OCIAD2 in Proben von Human. Er wurde validiert für WB, IHC (p), IF (cc), IF (p) und IHC (fro).

Kurzübersicht für OCIAD2 Antikörper (AA 65-154) (ABIN718031)

Target: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser OCIAD2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-OCIAD2 Antikörper

Bindungsspezifität: AA 65-154

Verwendungszweck: OCIAD2 Polyclonal Antibody

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human OCIAD2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB(1:300-5000),

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu OCIAD2

Target: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Andere Bezeichnung: OCIAD2

Hintergrund:

Synonyms: OCAD2_HUMAN, OCIA domain containing 2, OCIA domain-containing protein 2, OCIAD2, ovarian carcinoma immunoreactive antigen, Ovarian carcinoma immunoreactive antigen like protein, Ovarian carcinoma immunoreactive antigen-like protein.

Background: OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.

Gen-ID: 132299